MARKET

CSBR

CSBR

Champions
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.00
+0.35
+5.26%
Closed 16:00 04/07 EDT
OPEN
6.71
PREV CLOSE
6.65
HIGH
7.00
LOW
6.71
VOLUME
6.86K
TURNOVER
--
52 WEEK HIGH
10.44
52 WEEK LOW
4.020
MARKET CAP
83.21M
P/E (TTM)
-296.6102
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CSBR stock price target is 10.33 with a high estimate of 12.00 and a low estimate of 8.00.

EPS

CSBR News

More
  • Companies Like Champions Oncology (NASDAQ:CSBR) Can Afford To Invest In Growth
  • Simply Wall St. · 03/28 14:23
  • When Does Market Timing Actually Work? - March 16, 2020
  • Zacks · 03/16 13:35
  • SOHO, TLRY, CPLG and BLCM among midday movers
  • Seeking Alpha - Article · 03/13 16:44
  • Champions Oncology EPS in-line, beats on revenue
  • seekingalpha · 03/13 01:31

Industry

Biotechnology & Medical Research
-2.20%
Pharmaceuticals & Medical Research
-1.62%

Hot Stocks

Symbol
Price
%Change

About CSBR

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans. The TOS segment provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. Its TumorGraft Technology Platform consists of processes, physical tumors and information that it uses to personalize the development and use of oncology drugs. Each tumor from patients that it has preserved for implantation in mice, along with the patient data and molecular information associated with the tumors, are known as TumorGrafts or Patient Derived XenoGrafts of PDX Models. The collection of TumorGrafts is referred to as the Company's TumorBank.
More

Webull offers kinds of Champions Oncology Inc stock information, including NASDAQ:CSBR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSBR stock news, and many more online research tools to help you make informed decisions.